Celestica (NYSE:CLS) Stock Price Up 3.7% – Here’s Why

Celestica, Inc. (NYSE:CLSGet Free Report) (TSE:CLS)’s share price rose 3.7% during mid-day trading on Friday . The stock traded as high as $368.83 and last traded at $367.8060. Approximately 1,712,480 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 2,443,964 shares. The stock had previously closed at $354.77.

Wall Street Analysts Forecast Growth

CLS has been the subject of several research analyst reports. TD Cowen raised Celestica from a “hold” rating to a “buy” rating and increased their price objective for the stock from $350.00 to $430.00 in a research note on Wednesday, April 29th. TD Securities raised Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective for the company in a research note on Wednesday, April 29th. The Goldman Sachs Group reissued a “buy” rating and issued a $475.00 price objective on shares of Celestica in a research note on Tuesday, April 28th. Rothschild & Co Redburn began coverage on Celestica in a research note on Friday, May 1st. They issued a “buy” rating and a $460.00 price objective for the company. Finally, Barclays boosted their target price on Celestica from $391.00 to $441.00 and gave the company an “overweight” rating in a research note on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, Celestica presently has an average rating of “Moderate Buy” and an average target price of $427.42.

View Our Latest Research Report on CLS

Celestica Price Performance

The stock has a 50 day moving average price of $341.10 and a two-hundred day moving average price of $317.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.73 and a current ratio of 1.26. The company has a market capitalization of $42.29 billion, a PE ratio of 44.47, a P/E/G ratio of 0.85 and a beta of 2.09.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last posted its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.08. Celestica had a return on equity of 36.91% and a net margin of 6.95%.The company had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.97 billion. During the same period last year, the business earned $1.20 EPS. The business’s quarterly revenue was up 52.8% on a year-over-year basis. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Equities analysts forecast that Celestica, Inc. will post 9.5 earnings per share for the current year.

Insider Buying and Selling at Celestica

In other news, Director Michael Max Wilson sold 4,168 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the completion of the sale, the director directly owned 24,718 shares of the company’s stock, valued at $8,238,756.58. This trade represents a 14.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 1.10% of the stock is owned by company insiders.

Institutional Trading of Celestica

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Celestica by 1.5% in the fourth quarter. Vanguard Group Inc. now owns 4,811,695 shares of the technology company’s stock worth $1,423,333,000 after buying an additional 73,022 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Celestica by 24.8% in the fourth quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company’s stock worth $1,187,650,000 after buying an additional 798,782 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its position in shares of Celestica by 5,806,149.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company’s stock worth $1,081,323,000 after buying an additional 3,657,874 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its position in shares of Celestica by 471.5% in the third quarter. Arrowstreet Capital Limited Partnership now owns 3,146,928 shares of the technology company’s stock worth $775,133,000 after buying an additional 2,596,318 shares during the last quarter. Finally, Franklin Resources Inc. lifted its position in shares of Celestica by 18.6% in the fourth quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company’s stock worth $673,471,000 after buying an additional 356,797 shares during the last quarter. Institutional investors and hedge funds own 67.38% of the company’s stock.

About Celestica

(Get Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

Featured Articles

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.